Gut
Menopause & Diabetes Risk
How midlife hormones affect insulin, weight and diabetes risk — and how to protect yourself.
Oestrogen supports insulin sensitivity. After menopause, diabetes risk rises. Strength training, dietary tweaks and HRT can all improve metabolic health.
Type 2 diabetes risk rises measurably after menopause — and it does so quietly. Falling oestrogen, shifts in body composition and disturbed sleep all conspire to nudge insulin sensitivity in the wrong direction. The reassuring news is that this is one of the most reversible cardiometabolic changes of midlife: consistent strength training, sensible eating and adequate sleep can more than counterbalance the hormonal shift for the majority of women.
Why diabetes risk rises around menopause
- Oestrogen supports insulin sensitivity in muscle, fat and liver — its loss reduces glucose disposal.
- Visceral (abdominal) fat rises after menopause and is metabolically active, driving insulin resistance and inflammation.
- Poor sleep, night sweats and disrupted circadian rhythms worsen fasting glucose and HbA1c.
- South Asian, Black and mixed-heritage women have a higher baseline risk at any given BMI.
What lowers risk most (in order of impact)
- Progressive resistance training 2–3 times a week — the single highest-impact intervention in midlife women; muscle is the largest glucose sink in the body.
- 150 minutes moderate aerobic activity per week — brisk walking, cycling, swimming, dancing.
- Mediterranean-pattern eating: vegetables, pulses, olive oil, oily fish, wholegrains; low ultra-processed food.
- Adequate protein (~1.2g/kg/day) preserves lean mass and reduces post-meal glucose spikes.
- 7+ hours sleep, alcohol moderation and stopping smoking each pull in the right direction.
- HRT modestly improves insulin sensitivity in randomised trials — it is not a diabetes treatment, but transdermal HRT is a helpful adjunct where appropriate.
What to monitor
- HbA1c every 3 years from age 40 via NHS Health Check; more often if BMI > 30, family history, gestational diabetes history or high-risk ethnicity.
- Waist measurement (aim under 80 cm / 32 inches for women) — a better predictor than BMI in midlife.
- Blood pressure and lipids at the same time — cardiometabolic risk clusters.
Understanding your HbA1c
- Below 42 mmol/mol: normal.
- 42–47 mmol/mol: non-diabetic hyperglycaemia (pre-diabetes) — highly reversible with lifestyle change.
- 48 mmol/mol or above on two occasions: Type 2 diabetes.
If you already have Type 2 diabetes
- HRT is not contraindicated and can be part of a holistic menopause plan.
- Transdermal HRT is preferred — neutral effect on triglycerides and clotting.
- Continued input from your GP or diabetes team matters most; joint care between diabetes and menopause services works well.
- GLP-1 agonists (semaglutide, tirzepatide) can be used alongside HRT; menopausal muscle-preserving strategies matter even more on these medications.
Reversing pre-diabetes — what actually works
- 5–10% weight loss over 6–12 months, with the majority coming from visceral fat, typically returns HbA1c to normal.
- The NHS Diabetes Prevention Programme (self-refer or via GP) offers 9 months of structured support with strong outcomes.
- Strength training, protein-forward eating and adequate sleep are the highest-yield levers.
- Time-restricted eating (a 10–12 hour daily eating window) improves fasting insulin for many women.
Menopause, sleep and glucose — an under-recognised loop
- One poor night raises next-day insulin resistance by 20–30%.
- Treating night sweats often improves fasting glucose within weeks.
- Sleep apnoea (more common after menopause) drives insulin resistance and cardiovascular risk — screen if you snore, wake unrefreshed, or your partner notices pauses in breathing.
Key takeaway
Type 2 diabetes risk rises after menopause but responds beautifully to strength training, protein-rich Mediterranean eating and sleep — often more than to hormones. The single most important message is that pre-diabetes is not a life sentence; it is one of the most reversible conditions in midlife medicine.
How Dr Awal approaches this in clinic
Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.
- A detailed 60 minute first appointment — no rushed 10-minute slots.
- Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
- Body-identical HRT considered first-line where appropriate.
- Shared-care letters sent to your NHS GP so treatment can continue affordably.
- Follow-up at 3 months to fine-tune your regimen and address side effects.
- Ongoing annual reviews so your plan evolves with you.
Common questions we hear about this
Do I need to be at a certain age to be seen?
No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.
Will my GP continue the prescription?
In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.
What if I've tried HRT before and it didn't suit me?
Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.
How long will I need to stay on treatment?
There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.
Where do you see patients?
All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.
About the author
Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.
Sources & further reading
General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.
Talk it through
Book a private consultation with Dr Awal
Get evidence-based, personalised advice on menopause & diabetes risk and any related concerns.
Related in Gut
